Ace Vision Group

    News & Media

    Ace Vision Group Names Val Kolesnitchenko, MD, as Chief Scientific Officer

    Ace Vision Group announced that it has named Val Kolesnitchenko, MD, as Chief Scientific Officer. Dr. Kolesnitchenko has served in leadership roles for three decades in clinical ophthalmology practice and industry. Most recently, he held the position of Executive Director of Global Scientific Affairs at Bausch + Lomb, overseeing the medical and clinical development of the …

    read more

    The Modern Presbyopia Exam

    It’s time to move towards a more quantitative approach that can better guide treatments for presbyopia By James A. Katz, MD Presbyopia is a manifestation of the aging of the eye that is associated with near and intermediate blurry vision, headache, and eye strain or fatigue. In presbyopia, all of the tissues of the eye …

    read more

    VIDEO: Ace Vision Group provides update on presbyopia laser development

    SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, AnnMarie Hipsley, DPT, PhD, and Alex Lopez of Ace Vision Group provide an update on the development of the VisioLite ophthalmic laser for presbyopia. The company is in a Series B2 round of funding.

    read more

    Ace Vision Group Names Rob Kissling, MD, as Chief Medical Officer

    Ace Vision Group announced that it has named Rob Kissling, MD, as Chief Medical Officer. Dr. Kissling has more than 20 years of experience integrating clinical development, medical strategy, and business planning to develop and commercialize devices and medicines for ophthalmology. His tenure has included companies such as Pharmacia, Pfizer, and Novartis. Most recently, he …

    read more

    Ace Vision Group Adds Four Ophthalmologists to Medical Advisory Board; Launches New Corporate and Medical Affairs Websites

    Ace Vision Group announced the addition of Cathleen McCabe, MD;  James Katz, MD; Ehsan Sadri, MD; and Dagny Zhu, MD, to its medical advisory board. These prominent ophthalmologists will contribute expertise to advance the development and implementation of novel solutions for eye health, specifically Laser Scleral Microporation (LSM), a laser therapeutic designed to rejuvenate the …

    read more

    Dynamic range of focus recovery in presbyopes after laser scleral microporation

    While considered by many to be a “normal process of aging,” the loss of the dynamic focusing function of the eye, presbyopia, is a progressive disease of ocular aging. Presbyopia affects approximately 1.8 billion people globally.1 Estimated global annual productivity losses are approximately 0.037% of the global gross domesticproduct in presbyopic adults less than 65 years …

    read more
    1 2 3 4 5 9

    Laser scleral microporation: Unique method to treat presbyopia goes back to basics

    Laser scleral microporation is a unique therapeutic solution for presbyopia that goes back to basics, rejuvenating the eye and restoring the natural dynamic mechanism of accommodation and disaccommodation. “Nature frequently develops dynamic processes, which work well for most individuals for the first 40 or 50 years of life but then, because of changes in the intrinsic …

    read more

    Ace Vision Group to Present Nine New Sets of Scientific Data Focused on Laser Scleral Microporation at the ESCRS Annual Meeting

    Ace Vision Group (AVG) announced it will present nine sets of research on the effectiveness of Laser Scleral Microporation (LSM) at the annual congress of the European Society of Cataract and Refractive Surgeons (ESCRS).  LSM is an ultra-minimally invasive procedure with a novel therapeutic approach to treating the aging eye. 

    read more

    Dynamic Range of Focus of the Eye: Understanding Biomechanics and Kinematics: Part 1

    A PRIMARY FOCUS IN OPHthalmic health care has been on providing solutions to help our patients “see” more clearly and curtail the effects of uncurable age-related eye diseases, such as presbyopia, cataracts, glau-coma, and age-related macular degeneration (AMD). The eye contains more than 2 million working parts and is considered the second most complex organ …

    read more

    Improvement in Accommodation and Dynamic Range of Focus After Laser Scleral Microporation: A Potential Treatment for Presbyopia

    Purpose: To examine the ocular changes in accommodation, wavefront aberrations, and dynamic range of focus (DROF) after laser scleral microporation (LSM) for treating presbyopia.

    read more

    Unlocking the recovery of dynamic range of focus with microporation therapeutics

    Laser Scleral Microporation (LSM) is a therapy which represents the first biomechanical solution to the biomechanical problems of progressive presbyopia. The therapy is performed using the VisioLite® Ophthalmic Laser system developed by Ace Vision Group (AVG). Today, having no biomechanical option able to meet the loss of dynamic range of focus (DRoF) that occurs with progressive …

    read more

    Ocular Health Implications of the Loss of Dynamic Range of Focus Function in Presbyopia

    Presbyopia is defined as the eye’s loss of ability to focus on objects at near distances, and it is the most common cause of age-related vision impairment. Presbyopia is a significant global health issue that is underdiagnosed. It affects all people in their 40s and older: an estimated 90 million people in the United States …

    read more
    1 2 3 4 5 6

    ARVO LIVE: AI revolution in ophthalmology

    Ophthalmology Times® talked with AnnMarie Hipsley, DPT, PhD, about 3D finite element model used to understand more about the biomechanics of accommodation and dis-accommodation as it relates to functions for visual function as well as aqueous hydrodynamics at this year’s ARVO meeting.

    read more

    Robert Ang Discusses LSM by Ace Vision

    Robert T. Ang, refractive surgeon at the Asian Eye Institute in the Philippines, talks to The Ophthalmologist about the ways Laser Scleral Microporation (LSM) therapy offered by Ace Vision Group comes to benefit him and his patients. He discusses the therapy’s mechanism of action, what the procedure involves, and the unique value offered by LSM. …

    read more

    Laser scleral microporation improves near vision in emmetropic presbyopes

    WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, Robert E. Ang, MD, discusses results from a study of laser scleral microporation.

    read more

    The Future of the Aging Eye

    AnnMarie Hipsley, the Founder and CEO of Ace Vision Group (AVG), a Delaware, USA- based company developing innovative therapeutics for age-related ocular dysfunctions, talks to The Ophthalmologist about her background and work with AVG, and the company’s short- and long-term goals. She explains how the Group has utilized artificial intelligence and virtual reality platforms to …

    Show video

    Microporation may address aging in eye

    LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, AnnMarie Hipsley, DPT, PhD, discusses microporation therapeutics and its potential role in presbyopia treatment.

    read more

    Laser scleral microporation aids near vision without compromising distance vision

    LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, Robert Ang, MD, discusses results of laser scleral microporation in patients with presbyopia.

    read more
    1 2 3 4